Compare CSWC & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSWC | OGN |
|---|---|---|
| Founded | 1961 | 1923 |
| Country | United States | United States |
| Employees | 30 | N/A |
| Industry | Textiles | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2020 |
| Metric | CSWC | OGN |
|---|---|---|
| Price | $22.03 | $5.89 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $23.50 | $11.75 |
| AVG Volume (30 Days) | 570.5K | ★ 3.0M |
| Earning Date | 05-13-2026 | 04-30-2026 |
| Dividend Yield | ★ 11.92% | 1.40% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | N/A | ★ $6,216,000,000.00 |
| Revenue This Year | $17.45 | $0.42 |
| Revenue Next Year | $10.26 | $1.67 |
| P/E Ratio | $12.65 | ★ $7.92 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $17.47 | $5.69 |
| 52 Week High | $23.84 | $14.76 |
| Indicator | CSWC | OGN |
|---|---|---|
| Relative Strength Index (RSI) | 49.47 | 32.97 |
| Support Level | $21.30 | N/A |
| Resistance Level | $23.19 | $7.87 |
| Average True Range (ATR) | 0.47 | 0.23 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 75.44 | 28.57 |
Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.